Short-term changes of visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration.
Mitrut
I
I
Chua
P
P
Aslam
T
T
Vani
A
A
Ambrecht
A M
AM
Dhillon
B
B
D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D058449:Intravitreal Injections / Q000009:adverse effects; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy*; D000069579:Ranibizumab
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab